Steve Aselage insider trades: Biocryst Pharmaceuticals (BCRX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Steve reports to the SEC
Open-market buys and sales
63 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 24, 2024 | BCRX | ↑ Buy | 2,500 | $6.40 | $16K | By Trust | May 29, 2024 (5d) |
| Nov 29, 2022 | ACER | ↑ Buy | 409,836 | $1.22 | $500K | Direct | Dec 1, 2022 (2d) |
| May 11, 2022 | TVTX | ↓ Sell | 2,575 | $21.92 | $56K | Direct | May 12, 2022 (1d) |
| Dec 10, 2021 | ACER | ↑ Buy | 10,000 | $2.06 | $21K | Direct | Dec 13, 2021 (3d) |
| Nov 16, 2021 | TVTX | ↓ Sell | 31,800 | $29.39 | $935K | Direct | Nov 18, 2021 (2d) |
| Nov 5, 2021 | TVTX | ↓ Sell | 10,000 | $26.23 | $262K | Direct | Nov 9, 2021 (4d) |
| Nov 2, 2021 | TVTX | ↓ Sell | 8,500 | $29.69 | $252K | Indirect | Nov 3, 2021 (1d) |
| Oct 7, 2021 | TVTX | ↓ Sell | 60,000 | $26.25 | $1.6M | Direct | Oct 8, 2021 (1d) |
| May 11, 2021 | TVTX | ↓ Sell | 2,146 | $19.58 | $42K | Direct | May 13, 2021 (2d) |
| Apr 16, 2021 | TVTX | ↓ Sell | 10,000 | $26.23 | $262K | Direct | Apr 20, 2021 (4d) |
| Mar 17, 2021 | TVTX | ↓ Sell | 17,727 | $27.44 | $486K | Direct | Mar 19, 2021 (2d) |
| Feb 2, 2021 | TVTX | ↓ Sell | 25,000 | $30.75 | $769K | Direct | Feb 2, 2021 (0d) |
| Dec 15, 2020 | TVTX | ↓ Sell | 5,549 | $26.02 | $144K | Direct | Dec 16, 2020 (1d) |
| Dec 2, 2020 | TVTX | ↓ Sell | 7,891 | $23.43 | $185K | Direct | Dec 4, 2020 (2d) |
| Nov 6, 2020 | RTRX | ↓ Sell | 23,125 | $22.81 | $528K | Direct | Nov 6, 2020 (0d) |
| Aug 5, 2020 | RTRX | ↓ Sell | 2,500 | $19.68 | $49K | Direct | Aug 6, 2020 (1d) |
| Jul 24, 2020 | ACER | ↑ Buy | 45,000 | $3.50 | $158K | Direct | Jul 28, 2020 (4d) |
| Jun 25, 2020 | RTRX | ↓ Sell | 10,000 | $20.00 | $200K | Direct | Jun 29, 2020 (4d) |
| May 14, 2020 | RTRX | ↓ Sell | 8,125 | $16.00 | $130K | Direct | May 14, 2020 (0d) |
| May 5, 2020 | RTRX | ↓ Sell | 2,500 | $15.88 | $40K | Direct | May 6, 2020 (1d) |
| Mar 5, 2020 | RTRX | ↓ Sell | 4,359 | $15.36 | $67K | Direct | Mar 9, 2020 (4d) |
| Feb 5, 2020 | RTRX | ↓ Sell | 2,500 | $16.62 | $42K | Direct | Feb 7, 2020 (2d) |
| Nov 29, 2019 | RTRX | ↓ Sell | 5,000 | $13.91 | $70K | Direct | Nov 29, 2019 (0d) |
| Nov 18, 2019 | BCRX | ↑ Buy | 15,000 | $1.45 | $22K | Direct | Nov 18, 2019 (0d) |
| Jul 3, 2019 | ACER | ↑ Buy | 5,000 | $3.72 | $19K | Direct | Jul 5, 2019 (2d) |
| May 22, 2019 | BCRX | ↑ Buy | 3,000 | $3.57 | $11K | Direct | May 24, 2019 (2d) |
| May 15, 2019 | RTRX | ↓ Sell | 3,676 | $17.80 | $65K | Direct | May 16, 2019 (1d) |
| Mar 12, 2019 | BCRX | ↑ Buy | 2,000 | $8.30 | $17K | Direct | Mar 14, 2019 (2d) |
| Feb 12, 2019 | RTRX | ↓ Sell | 2,130 | $21.44 | $46K | Direct | Feb 13, 2019 (1d) |
| Dec 21, 2018 | RTRX | ↓ Sell | 12,376 | $21.88 | $271K | Direct | Dec 21, 2018 (0d) |
| Dec 7, 2018 | RTRX | ↓ Sell | 10 | $24.04 | $240 | Direct | Dec 7, 2018 (0d) |
| Nov 15, 2018 | RTRX | ↓ Sell | 11,100 | $24.03 | $267K | Direct | Nov 16, 2018 (1d) |
| Aug 31, 2018 | RTRX | ↓ Sell | 12,000 | $32.00 | $384K | Direct | Aug 31, 2018 (0d) |
| Dec 14, 2017 | ACER | ↑ Buy | 2,000 | $12.00 | $24K | Direct | Dec 18, 2017 (4d) |
| Jun 14, 2017 | RTRX | ↑ Buy | 5,000 | $17.85 | $89K | Direct | Jun 14, 2017 (0d) |
| Nov 22, 2016 | RTRX | ↓ Sell | 8,200 | $21.12 | $173K | Direct | Nov 23, 2016 (1d) |
| Nov 10, 2015 | RTRX | ↓ Sell | 60,000 | $18.75 | $1.1M | Direct | Nov 12, 2015 (2d) |
| Nov 21, 2014 | RTRX | ↑ Buy | 10,000 | $8.46 | $85K | Direct | Nov 21, 2014 (0d) |
| Aug 15, 2013 | RTRX | ↑ Buy | 556 | $4.50 | $3K | Direct | Dec 27, 2013 (134d) |
| Jul 2, 2012 | BMRN | ↓ Sell | 95,345 | $40.00 | $3.8M | Direct | Jul 5, 2012 (3d) |
| May 15, 2012 | BMRN | ↓ Sell | 10,000 | $38.64 | $386K | Direct | May 17, 2012 (2d) |
| May 11, 2012 | BMRN | ↓ Sell | 26,160 | $37.82 | $989K | Direct | May 15, 2012 (4d) |
| Oct 28, 2011 | BMRN | ↓ Sell | 16,875 | $35.00 | $591K | Direct | Oct 31, 2011 (3d) |
| May 26, 2011 | BMRN | ↓ Sell | 49,689 | $27.00 | $1.3M | Direct | May 26, 2011 (0d) |
| May 3, 2011 | BMRN | ↓ Sell | 10,311 | $27.15 | $280K | Direct | May 5, 2011 (2d) |
| Nov 18, 2010 | BMRN | ↓ Sell | 39,875 | $25.84 | $1.0M | Direct | Nov 19, 2010 (1d) |
| Sep 8, 2010 | BMRN | ↓ Sell | 35,000 | $22.00 | $770K | Direct | Sep 9, 2010 (1d) |
| Mar 8, 2010 | BMRN | ↓ Sell | 35,506 | $21.99 | $781K | Direct | Mar 8, 2010 (0d) |
| Mar 3, 2010 | BMRN | ↓ Sell | 10,000 | $21.00 | $210K | Direct | Mar 5, 2010 (2d) |
| Mar 2, 2010 | BMRN | ↓ Sell | 10,000 | $21.00 | $210K | Direct | Mar 3, 2010 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BCRX insiders
Open-market trades in the last 12 months
About Steve Aselage's insider trades
Steve Aselage is a director at Biocryst Pharmaceuticals (BCRX). Since Oct 31, 2006, Steve has reported 16 open-market purchases worth $1.0M and 47 sales worth $22.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (54 filings), option exercises (29 filings), gifts (7 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BCRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.